Afloat Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 32.21%
- Profit Growth -78.88%
- Ebitda -67.21%
- Net Worth 1.94%
- Total Assets 13.33%
About Afloat Pharma
Afloat Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 May 2017 (Seven years and eight months 23 days old ). Its registered office is in Bilaspur, Chattisgarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Tiwari, Utkarsh Tiwari, Prem Kumar, and Three other members serve as directors at the Company.
Company Details
-
Location
Bilaspur, Chattisgarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51900CT2017PTC007956
-
Company No.
007956
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 May 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chhattisgarh
Industry
Who are the key members and board of directors at Afloat Pharma?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Utkarsh Tiwari
|
Director | 19-May-2017 | Current |
|
Rakesh Tiwari
|
Director | 19-May-2017 | Current |
|
Prem Kumar
|
Director | 19-May-2017 | Current |
|
Sobhraj Chandani
|
Director | 19-May-2017 | Current |
|
Rishikesh Keshri
|
Director | 19-May-2017 | Current |
|
Manju Khanduja
|
Additional Director | 06-Apr-2018 | Current |
Financial Performance of Afloat Pharma.
Afloat Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.21% increase. The company also saw a substantial fall in profitability, with a 78.88% decrease in profit. The company's net worth moved up by a moderate rise of 1.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Afloat Pharma?
In 2021, Afloat Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Auro Educational FoundationRakesh Tiwari is a mutual person
-
Nkh Medicals Private Limited
Sobhraj Chandani is a mutual person
-
Nkh Medicare Private Limited
Sobhraj Chandani is a mutual person
-
Radian Pharma Private Limited
Rishikesh Keshri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Afloat Pharma?
Afloat Pharma has a workforce of 6 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Afloat Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Afloat Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
